ABSI

Absci
ABSI

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$367.83M
EV
$257.78M
Shares Outstanding
149.52M
Beta
2.02

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$8.13
P/E 2025E
-
P/Revenue 2025E
75.72x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Absci Corporation

gainify
ABSI

Absci Corporation

ABSI

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designe...

Sector

Healthcare

Industry

Biotechnology

CEO

McClain, Sean

Employees

157

IPO Date

2021-07-22

Headquarters

18105 SE Mill Plain Boulevard, Vancouver, Washington, 98683, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.